Status:
COMPLETED
DCS Study in Extremely Premature Newborns
Lead Sponsor:
Maria Angela Franceschini
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Premature Birth
Extremely Low Birth Weight
Eligibility:
All Genders
Up to 72 years
Phase:
NA
Brief Summary
The researchers are attempting to improve the cerebral monitoring of extremely low gestational age (ELGA) infants, such that in the future, real-time monitoring will be possible, to aid clinicians in ...
Detailed Description
Infants born at an extremely low gestational age (\<29 weeks GA) (ELGA) are at risk for developing any grade of intraventricular hemorrhage (IVH). In association with IVH, ELGA infants may develop ass...
Eligibility Criteria
Inclusion
- Premature infants born at \<29 weeks GA and \<48 hrs of age.
- No contraindication to DCS optical sensor placement on the scalp
- No major congenital anomalies,
- No Complex cyanotic congenital cardiac disease.
Exclusion
Key Trial Info
Start Date :
March 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04367181
Start Date
March 15 2019
End Date
May 31 2023
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115